Advanced search
Publication Cover
Disability and Rehabilitation Volume 44, 2022 - Issue 8
Submit an article Journal homepage
174
Views
3
CrossRef citations to date
0
Altmetric
Research Papers

Goal analysis in patients with limb spasticity treated with incobotulinumtoxinA in the TOWER study

Klemens Fheodoroffa Department of Neurorehabilitation, Gailtal-Klinik Hermagor, Hermagor, AustriaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6508-5055View further author information
ORCID Icon,
Astrid Scheschonkab Merz Pharmaceuticals GmbH, Frankfurt am Main, GermanyORCID Iconhttps://orcid.org/0000-0003-4745-0853View further author information
ORCID Icon &
Jörg Wisselc Department of Neurology & Neurorehabilitation and Physical Therapy, Vivantes Hospital Spandau, Berlin, GermanyORCID Iconhttps://orcid.org/0000-0001-6238-3578View further author information
ORCID Icon
Pages 1367-1373 | Received 20 Feb 2020, Accepted 29 Jul 2020, Published online: 17 Aug 2020

References

  • Levack WM, Weatherall M, Hay-Smith EJ, et al. Goal setting and strategies to enhance goal pursuit for adults with acquired disability participating in rehabilitation. Cochrane Database Syst Rev. 2015;(7):CD009727.
  • Lenzen SA, Daniels R, van Bokhoven MA, et al. Disentangling self-management goal setting and action planning: a scoping review. PLoS One. 2017;12(11):e0188822.
  • Wade DT. Goal setting in rehabilitation: an overview of what, why and how. Clin Rehabil. 2009;23(4):291–295.
  • Turner-Stokes L. Goal attainment scaling (GAS) in rehabilitation: a practical guide. Clin Rehabil. 2009;23(4):362–370.
  • Turner-Stokes L, Ashford S, Jacinto J, et al. Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III). BMJ Open. 2016;6(6):e011157.
  • Burke D, Wissel J, Donnan GA. Pathophysiology of spasticity in stroke. Neurology. 2013;80(3 Suppl 2):S20–S26.
  • Sommerfeld DK, Gripenstedt U, Welmer AK. Spasticity after stroke: an overview of prevalence, test instruments, and treatments. Am J Phys Med Rehabil. 2012;91(9):814–820.
  • Wissel J, Manack A, Brainin M. Toward an epidemiology of poststroke spasticity. Neurology. 2013;80(3 Suppl 2):S13–S19.
  • Urban PP, Wolf T, Uebele M, et al. Occurrence and clinical predictors of spasticity after ischemic stroke. Stroke. 2010;41(9):2016–2020.
  • Lundström E, Smits A, Terént A, et al. Time-course and determinants of spasticity during the first six months following first-ever stroke. J Rehabil Med. 2010;42(4):296–301.
  • Wissel J, Schelosky LD, Scott J, et al. Early development of spasticity following stroke: a prospective, observational trial. J Neurol. 2010;257(7):1067–1072.
  • Royal College of Physicians, British Society of Rehabilitation Medicine, Chartered Society of Physiotherapy, et al. Spasticity in adults: management using botulinum toxin: national guidelines. 2nd ed. London: Royal College of Physicians; 2018. [cited 2019 Oct 2]. Available from: https://www.rcplondon.ac.uk/sites/default/files/documents/spasticity-in-adults-management-botulinum-toxin.pdf
  • EuroQoL Group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.
  • World Health Organization. How to use the ICF: a practical manual for using the International Classification of Functioning, Disability and Health (ICF). Exposure draft for comment [Internet]. Geneva: World Health Organization; 2013. [cited 2019 Oct 2]. Available from: https://www.who.int/classifications/drafticfpracticalmanual2.pdf?ua=1
  • Constand MK, MacDermid JC. Applications of the International Classification of Functioning, Disability and Health in goal-setting practices in healthcare. Disabil Rehabil. 2014;36(15):1305–1314.
  • Gustafsson L, McLaughlin K. An exploration of clients' goals during inpatient and outpatient stroke rehabilitation. Int J Ther Rehabil. 2009;16(6):324–330.
  • Cieza A, Brockow T, Ewert T, et al. Linking health-status measurements to the international classification of functioning, disability and health. J Rehabil Med. 2002;34(5):205–210.
  • Cieza A, Fayed N, Bickenbach J, et al. Refinements of the ICF Linking Rules to strengthen their potential for establishing comparability of health information. Disabil Rehabil. 2019;41(5):574–583.
  • Wissel J, Bensmail D, Ferreira JJ, et al. Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: the TOWER study. Neurology. 2017;88(14):1321–1328.
  • Bovend'Eerdt TJ, Botell RE, Wade DT. Writing SMART rehabilitation goals and achieving goal attainment scaling: a practical guide. Clin Rehabil. 2009;23(4):352–361.
  • Braun JP, Mende H, Bause H, NeQuI (quality network in intensive care medicine), et al. Quality indicators in intensive care medicine: why? Use or burden for the intensivist. Ger Med Sci. 2010;8:Doc22.
  • Kiresuk TJ, Sherman RE. Goal attainment scaling: a general method for evaluating comprehensive community mental health programs. Community Ment Health J. 1968;4(6):443–453.
  • Lennon S, McKenna S, Jones F. Self-management programmes for people post stroke: a systematic review. Clin Rehabil. 2013;27(10):867–878.
  • Fheodoroff K, Rekand T, Medeiros L, et al. Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA. Health Qual Life Outcomes. 2020;18(1):51.
  • IPSEN. Validation of the Spasticity Related Quality of Life Questionnaire (SQOL-6D) [Internet]. ClinicalTrials.gov; 2019. [cited 2019 Dec 3]. Available from: https://clinicaltrials.gov/ct2/show/NCT03442660
  • Williams G, Singer BJ, Ashford S, et al. A synthesis and appraisal of clinical practice guidelines, consensus statements and Cochrane systematic reviews for the management of focal spasticity in adults and children. Disabil Rehabil. 2020.DOI:https://doi.org/10.1080/09638288.2020.1769207

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.